Fig. 2 | Scientific Reports

Fig. 2

From: Preclinical and clinical evaluation of [64Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [18F]FDG imaging

Fig. 2

Micro-PET/CT imaging in tumor models and SUVmax of each organ at 1, 4, 24 and 48 h after tail vein injection. (A) LNCaP C4-2B tumor mice scanned post-injection of [64Cu]Cu-PSMA-Q; (B) LNCaP C4-2B tumor mice scanned post-injection of [64Cu]Cu-PSMA-617; (C) PC-3 tumor mice scanned post-injection of [64Cu]Cu-PSMA-Q. The green arrow shows where the liver is. The red arrow shows the ___location of the tumor.

Back to article page